Arsenic trioxide induces selective tumour vascular damage via oxidative stress and increases thermosensitivity of tumours.
about
Nano-encapsulation of arsenic trioxide enhances efficacy against murine lymphoma model while minimizing its impact on ovarian reserve in vitro and in vivoRecent advances in arsenic trioxide encapsulated nanoparticles as drug delivery agents to solid cancersSodium arsenite and hyperthermia modulate cisplatin-DNA damage responses and enhance platinum accumulation in murine metastatic ovarian cancer xenograft after hyperthermic intraperitoneal chemotherapy (HIPEC)Use of a fluorescently labeled poly-caspase inhibitor for in vivo detection of apoptosis related to vascular-targeting agent arsenic trioxide for cancer therapy.Comparison of optical and power Doppler ultrasound imaging for non-invasive evaluation of arsenic trioxide as a vascular disrupting agent in tumors.Arterial embolization hyperthermia using As2O3 nanoparticles in VX2 carcinoma-induced liver tumors.Nanoparticle preconditioning for enhanced thermal therapies in cancerVascular disrupting agent arsenic trioxide enhances thermoradiotherapy of solid tumors.Effects of arsenic trioxide on radiofrequency ablation of VX2 liver tumor: intraarterial versus intravenous administrationSodium arsenite ± hyperthermia sensitizes p53-expressing human ovarian cancer cells to cisplatin by modulating platinum-DNA damage responsesTissue physiology and the response to heat.Development and modeling of arsenic-trioxide-loaded thermosensitive liposomes for anticancer drug deliveryAngiogenesis and vascular targeting: relevance for hyperthermia.Current status of antivascular therapy and targeted treatment in the clinic.Realistic biological approaches for improving thermoradiotherapy.Efficacy of Arsenic Trioxide in the Treatment of Malignant Pleural Effusion Caused by Pleural Metastasis of Lung Cancer.Assessing pH and oxygenation in cryotherapy-induced cytotoxicity and tissue response to freezing.Therapeutic potential of using the vascular disrupting agent OXi4503 to enhance mild temperature thermoradiation.A phase I study to study arsenic trioxide with radiation and hyperthermia in advanced head and neck cancer.
P2860
Q28488457-B5894F50-FA29-4FC4-9858-803948F7A3B5Q33768666-98C30430-B4C8-4386-8D4C-E2F582ECF3A1Q33940195-7F228286-5056-429D-9957-CAAECB56E53DQ34039403-6BB9FBF4-7277-47C3-86BE-AE035E9F87F9Q34430810-BD0E971D-8462-4D69-9EC2-1F4EFE645ED9Q34712590-D0A3ACC9-943B-4CF1-95E6-CEAECA587C40Q34987068-9D372CF9-996C-4765-ADB9-AABF670E9992Q35681405-1106B113-59FA-4723-B2AA-8D967B2B2F12Q35830597-1F0AC1E5-A282-4A77-9F4A-4D71381FAFE5Q35892810-0CEE09A0-EAAE-471E-B1CC-EBD79FC3D87FQ36497614-253D203F-7BDD-41E0-82EA-D6AECB6141AEQ36739924-1B0A9C30-36AC-4A5A-8A5B-5B09CF32F867Q37063496-B130FCCC-2682-47EF-9CB4-E00FD64FB330Q37063510-63AB8AF3-B323-4204-89F5-E78D2DADDBF9Q38648236-7BB2D047-7672-4FFD-881B-24B326D3DB5CQ38938729-428B84DD-9B02-45C7-AF8E-366020098C55Q40552361-BBA532C4-ED9C-428E-B763-C6717555A51BQ51029869-B96E96BA-26A9-47BE-8BEC-DC031B0E2C44Q53606948-B0EE957D-D14E-4DE2-BC52-2A1E18BB1655
P2860
Arsenic trioxide induces selective tumour vascular damage via oxidative stress and increases thermosensitivity of tumours.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Arsenic trioxide induces selec ...... thermosensitivity of tumours.
@en
type
label
Arsenic trioxide induces selec ...... thermosensitivity of tumours.
@en
prefLabel
Arsenic trioxide induces selec ...... thermosensitivity of tumours.
@en
P2093
P2860
P1476
Arsenic trioxide induces selec ...... thermosensitivity of tumours.
@en
P2093
P2860
P304
P356
10.1080/0265673031000124316
P577
2003-11-01T00:00:00Z